DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: Analysis of prognosis and current trends

World Journal of Surgery

Volumn 26, Issue 5, 2002, Pages 626-630

  Chen, Han Shiang ^a   Sheen Chen, Shyr Ming ^a   Lu, Chen Chang ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; COLORECTAL SURGERY; DNA DETERMINATION; FLOW CYTOMETRY; HISTOLOGY; HUMAN; PARAMETER; PLOIDY; PROGNOSIS; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; CELL CYCLE S PHASE; COLORECTAL TUMOR; FEMALE; GENETICS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

DNA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLOIDIES; PROGNOSIS; S PHASE;

EID: 0036559522     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0280-4     Document Type: Article

References (40)

1. Salud A, Porcel JM, Raikundalia B, et al. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J. Surg. Oncol. 1999;72:167-174
2. Tang R, Ho YS, You YT, et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer 1995;76:1724-1730
3. Chapman MA, Hardcastle JD, Armitage NC. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995;76:383-387
4. Beahrs OH, Henson DE, Hutter RV. Manual for Staging of Cancer, 3d edition, Philadelphia, Lippincott, 1988
5. American Joint Committee on Cancer. Colon and rectum. Philadelphia, Lippincott, In Manual for Staging of Cancer, 3d edition, Beahrs, OH, Henson, DE, Hutter, RV, editors, 1988:75-80
6. Williams NN, Daly JM. Flow cytometry and prognostic implications in patients with solid tumors. Surg. Gynecol. Obstet. 1990;171:257-266
7. Barlogie B, Raber MN, Schumann J. Flow cytometry in clinical cancer research. Cancer Res 1983;43:3982-3997
8. Seckinger D, Sugarbaker E, Frankfurt O. DNA content in human cancer: application and pathology and clinical. Arch. Pathol. Lab. Med. 1983;113:619-626
9. Quirke P, Dixon MF, Clayden AD, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J. Pathol. 1987;151:285-291
10. Schutte B, Reynders MM, Wiggers T, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res. 1987;47:5494-5496
11. Jass JR, Mukawa K, Goh HS, et al. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J. Clin. Pathol. 1989;42:254-259
12. Halvorsen TB, Johannesen E. DNA ploidy, tumor site, and prognosis in colorectal cancer: a flow cytometric study of paraffin-embedded tissue. Scand. J. Gastroenterol. 1990;25:141-148
13. Baretton G, Gille J, Oevermann E, et al.: Flow-cytometric analysis of DNA content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchows Arch. B Cell. Pathol. Mol. Pathol. 1991;60:123-131
14. Bosari S, Lee AK, Wiley BD, et al. Flow cytometric and image analyses of colorectal adenocarcinomas: a comparative study with clinical correlations. Am. J. Clin. Pathol. 1993;99:187-194
15. Chapman MA, Hardcastle JD, Armitage NC. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995;76:383-387
16. Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 1998;82:49-59
17. Witzig TE, Loprinzi CL, Gorichoroff NJ, et al. DNA plòidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 1991;68:879-888
18. Scott NA, Wieand HS, Moertel CG, et al. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch. Surg. 1987;122:1375-1379
19. Kokal WA, Gardine RL, Sheibani K, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann. Surg. 1989;209:188-193
20. Kouri M, Pyrhonen S, Mecklin JP, et al. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br. J. Cancer 1990;62:976-981
21. Rognum TO, Lund E, Meling GI, et al. Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 1991;68:1077-1081
22. Visscher DW, Zarbo RJ, Ma CK, et al. Flow cytometric DNA and clinicopathologic analysis of Dukes' A & B colonic adenocarcinomas: a retrospective study. Mod. Pathol. 1990;3:709-712
23. Enker WE, Kimmel M, Cibas ES, et al. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J. Natl. Cancer Inst. 1991;83:701-707
24. Zarbo RJ, Nakhleh RE, Brown RD, et al. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997;79:2073-2086
25. Hood DL, Petras RE, Edinger M, et al.: Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry: a prospective study of 137 cases using fresh whole cell suspensions. Am. J. Clin. Pathol. 1990;93:615-620
26. Bauer KD, Lincoln ST, Vera-Roman JM, et al. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab. Invest. 1987;57:329-335
27. Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 1983;31:1333-1335
28. Pinto AE, Chaves P, Fidalgo P, et al. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma. Dis. Colon Rectum 1997;40:411-419
29. Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma: a flow cytometric study with some methodological aspects. Cancer 1987;60:1282-1287
30. Armitage NC, Ballantyne KC, Sheffield JP, et al. A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer 1991;67:2599-2604
31. Jones DJ, Moore M, Schofield PF. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study. Int. J. Cancer 1988;41:206-210
32. Kim YJ, Ngoi SS, Godwin TA, et al. Ploidy in invasive colorectal cancer: implications for metastatic disease. Cancer 1991;68:638-641
33. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med. 1990;113:779-788
34. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 1994;331:213-221
35. Hamelin R, Laurent-Puig P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994;106:42-48
36. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol. 1994;145:148-156
37. Lanza G Jr, Maestri I, Ballotta MR, et al. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer. Mod. Pathol. 1994;7:161-165
38. Offerhaus GJ, De Feyter EP, Cornelisse CJ, et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992;102:1612-1619
39. Chen HH, Fan HA, Lin SE, et al. The correlation of DNA index with clinicopathologic parameters to the colorectal carcinoma: a prospective study. J Soc Colon Rectal Surgeons 1995;6:147-153
40. Dean PA, Vemava AM III. Flow cytometric analysis of DNA content in colorectal carcinoma. Dis. Colon Rectum 1992;35:95-102